WesBanco Bank’s Vertex Pharmaceuticals VRTX Stock Holding History

WesBanco Bank’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,401	Closed	-$845K	–	591
2023 Q2	$845K	Hold	2,401	–	–	0.04%	305
2023 Q1	$756K	Buy	2,401 +25	+1%	+$7.5K	0.03%	329
2022 Q4	$686K	Buy	+2,376	New	+$724K	0.03%	334
2022 Q3	–	Sell	-2,400	Closed	-$676K	–	523
2022 Q2	$676K	Buy	+2,400	New	+$642K	0.03%	333
2021 Q4	–	Sell	-6,065	Closed	-$1.1M	–	612
2021 Q3	$1.1M	Buy	+6,065	New	+$1.18M	0.04%	283

Other funds holding VRTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

WesBanco Bank's VRTX Position: Q3 2023 in Review

WesBanco Bank sold out of Vertex Pharmaceuticals (VRTX) in Q3 2023, closing a stake of 2,401 shares — an estimated $845K sold.

WesBanco Bank first reported a position in VRTX in Q3 2021 and held it in 5 quarters. The position peaked at $1.1M in Q3 2021. 1,277 funds tracked by Wall St. Rank hold VRTX as of Q3 2023.

WesBanco Bank reported no remaining Vertex Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
WesBanco Bank sold 2,401 Vertex Pharmaceuticals shares in Q3 2023, an estimated $845K.
WesBanco Bank first reported a position in Vertex Pharmaceuticals in Q3 2021 and held it in 5 quarters.
WesBanco Bank's Vertex Pharmaceuticals position peaked at $1.1M in Q3 2021.
1,277 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2023.

Based on WesBanco Bank's 13F filing for Q3 2023, filed 11 Dec 2023.